Page 103 - Read Online

Page 233 Xu et al. J Transl Genet Genom 2021;5:218-39 https://dx.doi.org/10.20517/jtgg.2021.20

considerations. Pediatr Radiol 2009;39 Suppl 1:S4-26. DOI PubMed PMC
13. Curtin K, Smith KR, Fraser A, Pimentel R, Kohlmann W, Schiffman JD. Familial risk of childhood cancer and tumors in the Li-
Fraumeni spectrum in the Utah Population Database: implications for genetic evaluation in pediatric practice. Int J Cancer
2013;133:2444-53. DOI PubMed PMC
14. Klco JM, Mullighan CG. Advances in germline predisposition to acute leukaemias and myeloid neoplasms. Nat Rev Cancer
2021;21:122-37. DOI PubMed
15. Treviño LR, Yang W, French D, et al. Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat
Genet 2009;41:1001-5. DOI PubMed PMC
16. Papaemmanuil E, Hosking FJ, Vijayakrishnan J, et al. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood
acute lymphoblastic leukemia. Nat Genet 2009;41:1006-10. DOI PubMed PMC
17. Sherborne AL, Hosking FJ, Prasad RB, et al. Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia
risk. Nat Genet 2010;42:492-4. DOI PubMed PMC
18. Ellinghaus E, Stanulla M, Richter G, et al. Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute
lymphoblastic leukemia. Leukemia 2012;26:902-9. DOI PubMed PMC
19. Xu H, Yang W, Perez-Andreu V, et al. Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in
ethnically diverse populations. J Natl Cancer Inst 2013;105:733-42. DOI PubMed PMC
20. Migliorini G, Fiege B, Hosking FJ, et al. Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic
leukemia and phenotype. Blood 2013;122:3298-307. DOI PubMed
21. Perez-Andreu V, Roberts KG, Harvey RC, et al. Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic
leukemia and risk of relapse. Nat Genet 2013;45:1494-8. DOI PubMed PMC
22. Walsh KM, de Smith AJ, Hansen HM, et al. A heritable missense polymorphism in CDKN2A confers strong risk of childhood acute
lymphoblastic leukemia and is preferentially selected during clonal evolution. Cancer Res 2015;75:4884-94. DOI PubMed PMC
23. Hungate EA, Vora SR, Gamazon ER, et al. A variant at 9p21.3 functionally implicates CDKN2B in paediatric B-cell precursor acute
lymphoblastic leukaemia aetiology. Nat Commun 2016;7:10635. DOI PubMed PMC
24. Vijayakrishnan J, Kumar R, Henrion MY, et al. A genome-wide association study identifies risk loci for childhood acute
lymphoblastic leukemia at 10q26.13 and 12q23.1. Leukemia 2017;31:573-9. DOI PubMed PMC
25. Clay-Gilmour AI, Hahn T, Preus LM, et al. Genetic association with B-cell acute lymphoblastic leukemia in allogeneic transplant
patients differs by age and sex. Blood Adv 2017;1:1717-28. DOI PubMed PMC
26. Wiemels JL, Walsh KM, de Smith AJ, et al. GWAS in childhood acute lymphoblastic leukemia reveals novel genetic associations at
chromosomes 17q12 and 8q24.21. Nat Commun 2018;9:286. DOI PubMed PMC
27. Vijayakrishnan J, Studd J, Broderick P, et al; PRACTICAL Consortium. Genome-wide association study identifies susceptibility loci
for B-cell childhood acute lymphoblastic leukemia. Nat Commun 2018;9:1340. DOI PubMed PMC
28. de Smith AJ, Walsh KM, Francis SS, et al. BMI1 enhancer polymorphism underlies chromosome 10p12.31 association with
childhood acute lymphoblastic leukemia. Int J Cancer 2018;143:2647-58. DOI PubMed PMC
29. Qian M, Xu H, Perez-Andreu V, et al. Novel susceptibility variants at the ERG locus for childhood acute lymphoblastic leukemia in
Hispanics. Blood 2019;133:724-9. DOI PubMed PMC
30. Qian M, Zhao X, Devidas M, et al. Genome-wide association study of susceptibility loci for T-cell acute lymphoblastic leukemia in
children. J Natl Cancer Inst 2019;111:1350-7. DOI PubMed PMC
31. de Smith AJ, Walsh KM, Morimoto LM, et al. Heritable variation at the chromosome 21 gene ERG is associated with acute
lymphoblastic leukemia risk in children with and without Down syndrome. Leukemia 2019;33:2746-51. DOI PubMed PMC
32. Vijayakrishnan J, Qian M, Studd JB, et al. Identification of four novel associations for B-cell acute lymphoblastic leukaemia risk. Nat
Commun 2019;10:5348. DOI PubMed PMC
33. Shah S, Schrader KA, Waanders E, et al. A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute
lymphoblastic leukemia. Nat Genet 2013;45:1226-31. DOI PubMed PMC
34. Gu Z, Churchman ML, Roberts KG, et al. PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia. Nat Genet
2019;51:296-307. DOI PubMed PMC
35. Noetzli L, Lo RW, Lee-Sherick AB, et al. Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis
and predisposition to lymphoblastic leukemia. Nat Genet 2015;47:535-8. DOI PubMed PMC
36. Zhang MY, Churpek JE, Keel SB, et al. Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy. Nat
Genet 2015;47:180-5. DOI PubMed PMC
37. Moriyama T, Metzger ML, Wu G, et al. Germline genetic variation in ETV6 and risk of childhood acute lymphoblastic leukaemia: a
systematic genetic study. Lancet Oncol 2015;16:1659-66. DOI PubMed PMC
38. Melazzini F, Palombo F, Balduini A, et al. Clinical and pathogenic features of ETV6-related thrombocytopenia with predisposition to
acute lymphoblastic leukemia. Haematologica 2016;101:1333-42. DOI PubMed PMC
39. Nishii R, Baskin-Doerfler R, Yang W, et al. Molecular basis of ETV6-mediated predisposition to childhood acute lymphoblastic
leukemia. Blood 2021;137:364-73. DOI PubMed PMC
40. Kuehn HS, Boisson B, Cunningham-Rundles C, et al. Loss of B cells in patients with heterozygous mutations in IKAROS. N Engl J
Med 2016;374:1032-43. DOI PubMed PMC
41. Yoshida N, Sakaguchi H, Muramatsu H, et al. Germline IKAROS mutation associated with primary immunodeficiency that
progressed to T-cell acute lymphoblastic leukemia. Leukemia 2017;31:1221-3. DOI PubMed
42. Churchman ML, Qian M, Te Kronnie G, et al. Germline genetic IKZF1 variation and predisposition to childhood acute lymphoblastic